[1] 律方,薛奇,邵康等.国际抗癌联盟-美国癌症联合委员会食管癌分期第7版临床应用的初步体会[J].中华肿瘤杂志,2012,34(6):461-464.
[2] Martin JT , Worni M,Zwischenberger JB,et al. The Role of Radiation Therapy in Resected T2 N0 Esophageal Cancer: A Population-Based Analysis[J]. Ann Thorac Surg, 2013, 95(2):453-458.
[3] 祖新慧,刘贵鹏.神经侵犯与宫颈癌临床病理特征的关系及预后分析[J].现代肿瘤医学,2018,26(5):754-758.
[4] Edge SB,Compton CC.The American joint committee on cancer: the 7th edition of the AJCC cancer staging manualand the future of TNM[J]. Ann Surg Oncol, 2010, 17(6):1471-1474.
[5] Liebig C,Ayala G,Wilks JA,et al. Perineural invasion in cancer : A Review of the Literature[J]. Cancer, 2009, 115(15):3379-3391.
[6] Chen TC,Wang CP,Ko JY,et al. The Impact of Perineural Invasion and/or Lymphovascular Invasion on the Survival of Early-Stage Oral Squamous Cell Carcinoma Patients[J]. Ann Surg Oncol, 2013, 20(7):2388-2395.
[7] Cho HC,Kim H,Cho HY,et al. Prognostic Significance of Perineural Invasion in Cervical Cancer[J].Int J Gynecol Pathol,2013, 32(2):228-233.
[8] Michael T,Anne-Kathrin T,Florian G, et al. Prognostic impact of perineural, blood and lymph vessel invasion for esophageal cancer[J]. Histol Histopathol, 2014, 172(2):239-240.
[9] 程波, 覃纲. 基质细胞衍生因子1及其受体趋化因子受体4生物学轴与头颈肿瘤[J]. 医学综述, 2016, 22(24):4828-4831.
[10] 李晖,姬荣伟.进展期胃癌中神经旁浸润与HER-2表达及其相关性分析[J].临床与实验病理学杂志,2017,33(2):178-182.
[11] D'Amico AV, Wu Y,Chen MH, et al. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer[J].J Urol,2001,165(1): 126-129.
[12] Xu G,Feng F,Liu Z,et al. Prognosis and Progression of ESCC Patients with Perineural Invasion[J]. Sci Rep, 2017, 7:43828.
[13] Tanaka A,Ishikawa S,Okuno K,et al. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer[J]. Hepatogastroenterology,2008,55(84):963-966. |
2020, Vol. 37 
